会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明专利
    • THIAZOLIDIN-4-ONE DERIVATIVES AND ACID ADDITION SALTS THEREOF
    • CA1338090C
    • 1996-02-27
    • CA567319
    • 1988-05-20
    • SUMITOMO PHARMA
    • ENOMOTO MASAOKOJIMA ATSUYUKIKOMURO YOSHIHIROMOROOKA SHIGEAKIAONO SHUNJISANEMITSU YUZURUMIZUTANI MASATOTANABE YOU
    • C07D417/04C07D417/14A61K31/44
    • Thiazolidin-4-one derivative represented by the following general formula (I) and acid addition salts thereof (I) wherein; R1 and R2 are the same or different and denote each (i) a residue represented by the general formula -A-R4 wherein, A denotes a single bond, C1-C8 alkylene, C2-C8 alkenylene, or C2-C8 alkynylene and R4 denotes hydrogen, C1-C12 alkyl, C2-C8 alkenyl, C3-C8 cycloalkyl, or C1-C6 haloalkyl, or (ii) a residue represented by the general formula wherein, B denotes a single bond or C1-C6 alkylene, R5 denotes hydrogen, C1-C6 alkyl, C2-C8 alkenyl, C3-C8 cycloalkyl, substituted silyl, or substituted or unsubstituted aryl, n and n' denote each an integer of 2 to 4, m denotes an integer of 1 to 3, and m' denotes an integer of 0 to 2; and R3 denotes hydrogen, C1-C2 alkyl, allyl, 2propynyl, or a residue represented by (a) the general formula (CH2)? R6 wherein, R6 denotes halogen, an aryl group substituted or unsubstituted by one or more hydroxy or C1-C4 alkoxy groups, or a residue represented by the general formula -D-R7 (D denotes oxygen or sulfur and R7 denotes hydrogen, C1-C4 alkyl, or C1-C4 alkanol) and ? denotes an integer of 2 to 4, (b) the general formula ?CH2? CO-E-R8 wherein, E denotes oxygen, sulfur, imino, or C1-C4 alkylimino, R8 denotes hydrogen or C1-C4 alkyl, or -(E-R8) denotes a 5- to 7-membered cyclic amino group which optionally contains other hetero atoms, and k denotes an integer of 1 to 3, or (c) the general formula - F-R9 wherein, F denotes C2-C6 alkylene and R9 denotes a nitrogen-containing heterocyclic aromatic residue or an amino group represented by the general formula (R10 denotes hydrogen, C1-C4 alkyl, or C1-C4 alkyl or R10 in combination with R11 denotes a 5- to
    • 8. 发明专利
    • DE3873167D1
    • 1992-09-03
    • DE3873167
    • 1988-05-20
    • SUMITOMO PHARMA
    • ENOMOTO MASAOKOJIMA ATSUYUKIKOMURO YOSHIHIROMOROOKA SHIGEAKIAONO SHUNJISANEMITSU YUZURUMIZUTANI MASATOTANABE YOU
    • C07D417/04A61K31/44
    • Thiazolidin-4-one derivatives are represented by the following general formula (I) wherein; R and R are the same or different and denote each (i) a residue represented by the general formula -A-R wherein, A denotes a single bond, C1-C8 alkylene, C2-C8 alkenylene, or C2-C8 alkynylene and R denotes hydrogen, C1-C12 alkyl, C2-C8 alkenyl, C3-C8 cycloalkyl, or C1-C6 haloalkyl, or (ii) a residue represented by the general formula wherein, B denotes a single bond or C1-C6 alkylene, R denotes hydrogen, C1-C6 alkyl, C2-C8 alkenyl, C3-C8 cycloalkyl, substituted silyl, or substituted or unsubstituted aryl, n and n min denote each an integer of 2 to 4, m denotes an integer of 1 to 3, and m min denotes an integer of 0 to 2; and R denotes hydrogen, C1-C2 alkyl, allyl, 2-propynyl, or a residue represented by (a) the general formula @@@CH2@ @@R wherein, R denotes halogen, an aryl group substituted or unsubstituted by one or more hydroxy or C1-C4 alkoxy groups, or a residue represented by the general formula -D-R (D denotes oxygen or sulfur and R denotes hydrogen, C1-C4 alkyl, or C1-C4 alkanol) and l denotes an integer of 2 to 4, (b) the general formula @@@CH2@ @@CO-E-R wherein, E denotes oxygen, sulfur, imino, or C1-C4 alkylimino, R denotes hydrogen or C1-C4 alkyl, or -(E-R ) denotes a 5- to 7-membered cyclic amino group which optionally contains other hetero atoms, and k denotes an integer of 1 to 3, or (c) the general formula -F-R wherein, F denotes C2-C6 alkylene and R denotes a nitrogen-containing heterocyclic aromatic residue or an amino group represented by the general formula (R denotes hydrogen, C1-C4 alkyl, or C1-C4 alkyl or R in combination with R denotes a 5- to 7-membered cyclic amino group which optionally contains other hetero atoms), with the proviso that, when R is hydrogen and R is methyl, R denotes hydrogen, C1-C2 alkyl, 2-propynyl, or a residue represented by (a) the general formula @@@CH2@ @@R wherein, R denotes halogen, an aryl group substituted or unsubstituted by one or more hydroxy or C1-C4 alkoxy groups, or a residue represented by the general formula -D-R (D denotes oxygen or sulfur and R denotes hydrogen, C1-C4 alkyl, or C1-C4 alkanoyl) and l denotes an integer of 2 to 4, (b) the general formula @@CH2@@ @CO-E-R wherein, E denotes oxygen, sulfur, imino, or C1-C4 alkylimino, denotes hydrogen or C1-C4 alkyl, or -(E-R ) denotes a 5- to 7-membered cyclic amino group which optionally contains other hetero atoms, and k denotes an integer of 1 to 3, or (c) the general formula -F-R wherein, F denotes C2-C6 alkylene and R denotes a nitrogen-containing heterocyclic aromatic residue or an amino group represented by the general formula (R denotes hydrogen, C2-C4 alkyl or C1-C4 alkanoyl and R denotes hydrogen or C1-C4 alkyl or R in combination with R denotes a 5- to 7-membered cyclic amino group which optionally contains other hetero atoms. Since these derivatives, and acid addition salts thereof have selective PAF-antagonistic activities, these compounds are very useful as preventive and curative agents for PAF-induced diseases, for example, various kinds of inflamation, allergic diseases, circulatory diseases, and gastro-intestinal diseases.
    • 10. 发明专利
    • DE3873167T2
    • 1992-12-03
    • DE3873167
    • 1988-05-20
    • SUMITOMO PHARMA
    • ENOMOTO MASAOKOJIMA ATSUYUKIKOMURO YOSHIHIROMOROOKA SHIGEAKIAONO SHUNJISANEMITSU YUZURUMIZUTANI MASATOTANABE YOU
    • C07D417/04A61K31/44
    • Thiazolidin-4-one derivatives are represented by the following general formula (I) wherein; R and R are the same or different and denote each (i) a residue represented by the general formula -A-R wherein, A denotes a single bond, C1-C8 alkylene, C2-C8 alkenylene, or C2-C8 alkynylene and R denotes hydrogen, C1-C12 alkyl, C2-C8 alkenyl, C3-C8 cycloalkyl, or C1-C6 haloalkyl, or (ii) a residue represented by the general formula wherein, B denotes a single bond or C1-C6 alkylene, R denotes hydrogen, C1-C6 alkyl, C2-C8 alkenyl, C3-C8 cycloalkyl, substituted silyl, or substituted or unsubstituted aryl, n and n min denote each an integer of 2 to 4, m denotes an integer of 1 to 3, and m min denotes an integer of 0 to 2; and R denotes hydrogen, C1-C2 alkyl, allyl, 2-propynyl, or a residue represented by (a) the general formula @@@CH2@ @@R wherein, R denotes halogen, an aryl group substituted or unsubstituted by one or more hydroxy or C1-C4 alkoxy groups, or a residue represented by the general formula -D-R (D denotes oxygen or sulfur and R denotes hydrogen, C1-C4 alkyl, or C1-C4 alkanol) and l denotes an integer of 2 to 4, (b) the general formula @@@CH2@ @@CO-E-R wherein, E denotes oxygen, sulfur, imino, or C1-C4 alkylimino, R denotes hydrogen or C1-C4 alkyl, or -(E-R ) denotes a 5- to 7-membered cyclic amino group which optionally contains other hetero atoms, and k denotes an integer of 1 to 3, or (c) the general formula -F-R wherein, F denotes C2-C6 alkylene and R denotes a nitrogen-containing heterocyclic aromatic residue or an amino group represented by the general formula (R denotes hydrogen, C1-C4 alkyl, or C1-C4 alkyl or R in combination with R denotes a 5- to 7-membered cyclic amino group which optionally contains other hetero atoms), with the proviso that, when R is hydrogen and R is methyl, R denotes hydrogen, C1-C2 alkyl, 2-propynyl, or a residue represented by (a) the general formula @@@CH2@ @@R wherein, R denotes halogen, an aryl group substituted or unsubstituted by one or more hydroxy or C1-C4 alkoxy groups, or a residue represented by the general formula -D-R (D denotes oxygen or sulfur and R denotes hydrogen, C1-C4 alkyl, or C1-C4 alkanoyl) and l denotes an integer of 2 to 4, (b) the general formula @@CH2@@ @CO-E-R wherein, E denotes oxygen, sulfur, imino, or C1-C4 alkylimino, denotes hydrogen or C1-C4 alkyl, or -(E-R ) denotes a 5- to 7-membered cyclic amino group which optionally contains other hetero atoms, and k denotes an integer of 1 to 3, or (c) the general formula -F-R wherein, F denotes C2-C6 alkylene and R denotes a nitrogen-containing heterocyclic aromatic residue or an amino group represented by the general formula (R denotes hydrogen, C2-C4 alkyl or C1-C4 alkanoyl and R denotes hydrogen or C1-C4 alkyl or R in combination with R denotes a 5- to 7-membered cyclic amino group which optionally contains other hetero atoms. Since these derivatives, and acid addition salts thereof have selective PAF-antagonistic activities, these compounds are very useful as preventive and curative agents for PAF-induced diseases, for example, various kinds of inflamation, allergic diseases, circulatory diseases, and gastro-intestinal diseases.